AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MNPR
  4. [Form 4] Monopar Therapeutics Inc. Insider Trading Activity

[Form 4] Monopar Therapeutics Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock MNPR logo
Monopar Therapeutics Inc

NASDAQ:MNPR

MNPR Rankings

#4069 Ranked by Market Cap
N/A Ranked by Dividends

MNPR Latest News

Aug 12, 2025
Monopar Therapeutics Reports Second聽Quarter 2025聽Financial Results and Recent Developments
Jun 11, 2025
Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
Jun 3, 2025
Monopar Therapeutics Announces Inclusion in the Russell 3000庐 and Russell 2000庐 Indexes
May 13, 2025
Monopar Therapeutics Reports First聽Quarter 2025聽Financial Results and Recent Developments
May 7, 2025
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

MNPR Latest SEC Filings

Aug 12, 2025
[8-K] Monopar Therapeutics Inc. Reports Material Event
Aug 12, 2025
[10-Q] Monopar Therapeutics Inc. Quarterly Earnings Report
Jul 16, 2025
[Form 4] Monopar Therapeutics Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Monopar Therapeutics Inc. Insider Trading Activity
Jul 14, 2025
[144] Monopar Therapeutics Inc. SEC Filing

MNPR Stock Data

211.89M
4.00M
34.56%
47.59%
2.23%
Biotechnology
Pharmaceutical Preparations
United States
WILMETTE